Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A
Clinical trial NCT02572817 · COMPLETED
Trial details
- NCT number
- NCT02572817
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-04-26
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.